Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-02-11
1987-11-17
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, A61K 3141, C07D25704
Patent
active
047074884
ABSTRACT:
The compounds of this invention are 1-phenylalkyl-2-mercaptotetrazole compounds which are dopamine-.beta.-hydroxylase inhibitors.
REFERENCES:
patent: 2386869 (1945-10-01), Kendal
patent: 3437665 (1969-04-01), Maggiulli
patent: 4110338 (1978-08-01), Kamiya et al.
L'abbe et al., J. Org. Chem. 41:1875-1876 (1976), Altland, J. Org. Chem. 41:3395-3399 (1976).
Lieber et al., Canadian J. Chem. 37:101-109 (1959).
Nirenburg et al., Chem. Abstracts, 63 11544b (1969).
Kaiser Carl
Kruse Lawrence I.
Bond Robert T.
Fabiano Vincent L.
Lourie Alan D.
SmithKline Beckman Corporation
Springer D. B.
LandOfFree
Dopamine-.beta.-hydroxylase inhibitors and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine-.beta.-hydroxylase inhibitors and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine-.beta.-hydroxylase inhibitors and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450389